Drug Type Antibody drug conjugate (ADC) |
Synonyms LM 317, LM-317, LM317 |
Target |
Action modulators, inhibitors |
Mechanism NaPi-2b modulators(Sodium-dependent phosphate transport protein 2B modulators), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | China | 22 Mar 2024 |






